Stay updated on Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The new screenshot shows minor formatting and wording updates on the Study Details page that do not affect core information such as eligibility criteria, outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-28T05:09:47.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Updated release notes: version bumped to v3.2.0 and added a government-status notice; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T15:57:39.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T09:52:07.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page version has been upgraded from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T23:57:18.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T20:36:17.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location in Taipei, Taiwan, along with relevant publications from PubMed related to cancer treatment. Additionally, several previous terms and resources have been removed, including specific cancer-related topics and location details.
    Difference
    8%
    Check dated 2025-08-31T12:58:17.000Z thumbnail image

Stay in the know with updates to Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.